This project aims to determine the proportion of presumptive Tuberculosis (TB) lymphadenitis attributable to Mycobacterium TB complex and the proportion of confirmed TB lymphadenitis attributable to Mycobacterium bovis.
TB is now the leading cause of death amongst infectious diseases worldwide. In the Pacific region it is an important health issue. Papua New Guinea (PNG) is listed by the World Health Organization as one of 30 high TB burden countries, with an estimated incidence rate of 432 per 100,000 population, and an incidence of multi-drug resistant TB of 23 per 100,000.
The Mycobacterium TB complex is a group of closely related acid-fast bacilli including Mycobacterium TB and Mycobacterium bovis. Both domestic and wild animal species are hosts for Mycobacterium bovis. While Mycobacterium TB is avirulent in cattle and transmission back to humans is extremely rare, Mycobacterium bovis can infect humans and humans can infect livestock.
This project addresses two major gaps in TB care and response in PNG. Firstly, defining what proportion of clinically diagnosed TB lymphadenitis is due to drug-sensitive and drug-resistant TB, which will have implications for clinical and programmatic management of TB. Secondly, this may demonstrate that a large proportion of clinically diagnosed cases are negative for TB by molecular and culture methods, suggesting that other pathogens may be responsible and requiring a change in clinical diagnostic algorithms.
This project is part of the Research for One Health Systems Strengthening Program co-funded with DFAT addressing zoonoses, antimicrobial resistance and systems strengthening within the Asia Pacific.
- Determining the proportion of presumptive TB lymphadenitis attributable to Mycobacterium tuberculosis complex in East New Britain and Eastern Highlands provinces.
- Determining the proportion of confirmed TB lymphadenitis attributable to Mycobacterium bovis in East New Britain and Eastern Highlands provinces.
- Exploring animal-human interactions that may pose a risk for zoonotic infections.
- Developing a prospective cohort study of presumptive TB lymphadenitis.
- Exploring ethnographic research into animal-human interactions that may pose a risk for zoonotic infections.
- Establishing a stored bank of lymph node and blood samples for future studies on other potential causes of lymphadenitis.
Summary of achievements to date
EZARET (Exploring Zoonotic Association and Risks for Extrapulmonary Tuberculosis in Papua New Guinea) is a research study aiming to evaluate the proportion of lymphadenitis attributable to tuberculosis, what proportion of detected tuberculosis is resistant to standard treatment, and whether there are any cases of Mycobacterium bovis detected, which can have important implications for public health management strategies.
The research is also examining whether there are important human-animal interactions that may pose a risk for zoonotic infections in the study community. The key partners for this project are the National TB Program, PNG Institute of Medical Research, the Burnet Institute, Port Moresby General Hospital, East New Britain Provincial Health Authority, Eastern Highlands Provincial Health Authority and the Victorian Infectious Diseases Reference Laboratory.
The lymph node sampling aspect of the study has been completed at the Port Moresby site, nearly completed in the Eastern Highlands site, and about to start in the East New Britain site.
Focus group discussions with community members exploring animal-human interactions have been held in two sites and have been analysed, and interpretation and reporting is proceeding. In-depth interviews with people who provided fine needle aspirate samples have not yet commenced. The study has been challenged by repeated delays mostly resulting directly or indirectly from the COVID-19 pandemic.